nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefixime—SLC15A2—melanoma	0.75	1	CbGaD
Cefixime—SLC22A5—Dactinomycin—melanoma	0.176	1	CbGbCtD
Cefixime—Meningitis—Carmustine—melanoma	0.00252	0.0382	CcSEcCtD
Cefixime—Nephropathy toxic—Bleomycin—melanoma	0.00195	0.0296	CcSEcCtD
Cefixime—Drug fever—Docetaxel—melanoma	0.00188	0.0285	CcSEcCtD
Cefixime—Nephropathy toxic—Carmustine—melanoma	0.0017	0.0258	CcSEcCtD
Cefixime—Cholestasis—Temozolomide—melanoma	0.00124	0.0189	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.00121	0.0183	CcSEcCtD
Cefixime—Eosinophilia—Vemurafenib—melanoma	0.00115	0.0174	CcSEcCtD
Cefixime—Hyperbilirubinaemia—Temozolomide—melanoma	0.00104	0.0157	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.00102	0.0155	CcSEcCtD
Cefixime—Aplastic anaemia—Dactinomycin—melanoma	0.00098	0.0149	CcSEcCtD
Cefixime—Vaginal inflammation—Temozolomide—melanoma	0.000944	0.0143	CcSEcCtD
Cefixime—Candida infection—Carmustine—melanoma	0.000933	0.0141	CcSEcCtD
Cefixime—Candida infection—Temozolomide—melanoma	0.000901	0.0137	CcSEcCtD
Cefixime—Vaginal infection—Temozolomide—melanoma	0.000891	0.0135	CcSEcCtD
Cefixime—Aplastic anaemia—Temozolomide—melanoma	0.000886	0.0134	CcSEcCtD
Cefixime—Erythema multiforme—Vemurafenib—melanoma	0.000877	0.0133	CcSEcCtD
Cefixime—Ceftibuten—SLC15A2—melanoma	0.000864	0.135	CrCbGaD
Cefixime—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A2—melanoma	0.000846	0.387	CbGpPWpGaD
Cefixime—Cefepime—SLC15A2—melanoma	0.000712	0.111	CrCbGaD
Cefixime—Hyperbilirubinaemia—Docetaxel—melanoma	0.00069	0.0105	CcSEcCtD
Cefixime—Face oedema—Carmustine—melanoma	0.000685	0.0104	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.000682	0.0103	CcSEcCtD
Cefixime—Pancytopenia—Bleomycin—melanoma	0.000667	0.0101	CcSEcCtD
Cefixime—Blood bilirubin increased—Docetaxel—melanoma	0.000664	0.0101	CcSEcCtD
Cefixime—Face oedema—Temozolomide—melanoma	0.000662	0.01	CcSEcCtD
Cefixime—Anaphylactic shock—Vemurafenib—melanoma	0.000659	0.01	CcSEcCtD
Cefixime—Cefuroxime—SLC15A2—melanoma	0.000644	0.101	CrCbGaD
Cefixime—Pancytopenia—Dactinomycin—melanoma	0.000622	0.00943	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Temozolomide—melanoma	0.000617	0.00936	CcSEcCtD
Cefixime—Neutropenia—Dactinomycin—melanoma	0.000612	0.00929	CcSEcCtD
Cefixime—Colitis—Docetaxel—melanoma	0.000603	0.00914	CcSEcCtD
Cefixime—Candida infection—Docetaxel—melanoma	0.000599	0.00909	CcSEcCtD
Cefixime—Pancytopenia—Carmustine—melanoma	0.000582	0.00883	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000579	0.00878	CcSEcCtD
Cefixime—Neutropenia—Carmustine—melanoma	0.000573	0.00869	CcSEcCtD
Cefixime—Haemoglobin—Bleomycin—melanoma	0.000565	0.00857	CcSEcCtD
Cefixime—Pancytopenia—Temozolomide—melanoma	0.000562	0.00853	CcSEcCtD
Cefixime—Haemorrhage—Bleomycin—melanoma	0.000562	0.00853	CcSEcCtD
Cefixime—Neutropenia—Temozolomide—melanoma	0.000554	0.0084	CcSEcCtD
Cefixime—Agranulocytosis—Dactinomycin—melanoma	0.000545	0.00827	CcSEcCtD
Cefixime—Renal failure—Carmustine—melanoma	0.000537	0.00815	CcSEcCtD
Cefixime—Urinary tract infection—Carmustine—melanoma	0.000531	0.00806	CcSEcCtD
Cefixime—Hepatitis—Dactinomycin—melanoma	0.000524	0.00795	CcSEcCtD
Cefixime—Ceftazidime—SLC15A2—melanoma	0.000524	0.0817	CrCbGaD
Cefixime—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000524	0.00794	CcSEcCtD
Cefixime—Body temperature increased—Vemurafenib—melanoma	0.000521	0.0079	CcSEcCtD
Cefixime—Cefdinir—SLC15A2—melanoma	0.000514	0.0802	CrCbGaD
Cefixime—Urinary tract infection—Temozolomide—melanoma	0.000513	0.00779	CcSEcCtD
Cefixime—Cefaclor—SLC15A2—melanoma	0.000509	0.0795	CrCbGaD
Cefixime—Erythema multiforme—Dactinomycin—melanoma	0.000496	0.00752	CcSEcCtD
Cefixime—Haemoglobin—Carmustine—melanoma	0.000493	0.00748	CcSEcCtD
Cefixime—Haemorrhage—Carmustine—melanoma	0.000491	0.00744	CcSEcCtD
Cefixime—Cefradine—SLC15A2—melanoma	0.000488	0.0762	CrCbGaD
Cefixime—Hypersensitivity—Vemurafenib—melanoma	0.000485	0.00737	CcSEcCtD
Cefixime—Renal impairment—Docetaxel—melanoma	0.000479	0.00726	CcSEcCtD
Cefixime—Dermatitis bullous—Docetaxel—melanoma	0.000477	0.00723	CcSEcCtD
Cefixime—Haemoglobin—Temozolomide—melanoma	0.000476	0.00723	CcSEcCtD
Cefixime—Hepatitis—Temozolomide—melanoma	0.000474	0.00719	CcSEcCtD
Cefixime—Haemorrhage—Temozolomide—melanoma	0.000474	0.00719	CcSEcCtD
Cefixime—Pruritus—Vemurafenib—melanoma	0.000466	0.00707	CcSEcCtD
Cefixime—Cefadroxil—SLC15A2—melanoma	0.000462	0.0721	CrCbGaD
Cefixime—Diarrhoea—Vemurafenib—melanoma	0.000451	0.00684	CcSEcCtD
Cefixime—Erythema multiforme—Temozolomide—melanoma	0.000448	0.0068	CcSEcCtD
Cefixime—Leukopenia—Bleomycin—melanoma	0.000438	0.00664	CcSEcCtD
Cefixime—Dizziness—Vemurafenib—melanoma	0.000436	0.00661	CcSEcCtD
Cefixime—Vomiting—Vemurafenib—melanoma	0.000419	0.00636	CcSEcCtD
Cefixime—Rash—Vemurafenib—melanoma	0.000415	0.0063	CcSEcCtD
Cefixime—Dermatitis—Vemurafenib—melanoma	0.000415	0.0063	CcSEcCtD
Cefixime—Headache—Vemurafenib—melanoma	0.000413	0.00626	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Docetaxel—melanoma	0.00041	0.00623	CcSEcCtD
Cefixime—Leukopenia—Dactinomycin—melanoma	0.000408	0.0062	CcSEcCtD
Cefixime—Cefotaxime—SLC15A2—melanoma	0.000403	0.0628	CrCbGaD
Cefixime—Anaphylactic shock—Bleomycin—melanoma	0.000399	0.00606	CcSEcCtD
Cefixime—Ceftriaxone—SLC15A2—melanoma	0.000397	0.0619	CrCbGaD
Cefixime—Nausea—Vemurafenib—melanoma	0.000391	0.00594	CcSEcCtD
Cefixime—Thrombocytopenia—Bleomycin—melanoma	0.000391	0.00593	CcSEcCtD
Cefixime—Leukopenia—Carmustine—melanoma	0.000382	0.0058	CcSEcCtD
Cefixime—Angioedema—Temozolomide—melanoma	0.000377	0.00572	CcSEcCtD
Cefixime—Pancytopenia—Docetaxel—melanoma	0.000374	0.00567	CcSEcCtD
Cefixime—Convulsion—Carmustine—melanoma	0.00037	0.00561	CcSEcCtD
Cefixime—Leukopenia—Temozolomide—melanoma	0.000369	0.0056	CcSEcCtD
Cefixime—Neutropenia—Docetaxel—melanoma	0.000368	0.00559	CcSEcCtD
Cefixime—Thrombocytopenia—Dactinomycin—melanoma	0.000365	0.00553	CcSEcCtD
Cefixime—Convulsion—Temozolomide—melanoma	0.000358	0.00542	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000348	0.00528	CcSEcCtD
Cefixime—Cefalotin—SLC15A2—melanoma	0.000348	0.0542	CrCbGaD
Cefixime—Renal failure—Docetaxel—melanoma	0.000345	0.00524	CcSEcCtD
Cefixime—Jaundice—Docetaxel—melanoma	0.000342	0.00519	CcSEcCtD
Cefixime—Thrombocytopenia—Carmustine—melanoma	0.000341	0.00518	CcSEcCtD
Cefixime—Anaphylactic shock—Temozolomide—melanoma	0.000337	0.00511	CcSEcCtD
Cefixime—Thrombocytopenia—Temozolomide—melanoma	0.00033	0.005	CcSEcCtD
Cefixime—Agranulocytosis—Docetaxel—melanoma	0.000328	0.00497	CcSEcCtD
Cefixime—Urticaria—Bleomycin—melanoma	0.000317	0.00481	CcSEcCtD
Cefixime—Haemoglobin—Docetaxel—melanoma	0.000317	0.00481	CcSEcCtD
Cefixime—Cephalexin—SLC15A2—melanoma	0.000316	0.0493	CrCbGaD
Cefixime—Body temperature increased—Bleomycin—melanoma	0.000316	0.00479	CcSEcCtD
Cefixime—Haemorrhage—Docetaxel—melanoma	0.000315	0.00478	CcSEcCtD
Cefixime—Hepatitis—Docetaxel—melanoma	0.000315	0.00478	CcSEcCtD
Cefixime—Gastrointestinal pain—Dactinomycin—melanoma	0.000304	0.00462	CcSEcCtD
Cefixime—Erythema multiforme—Docetaxel—melanoma	0.000298	0.00452	CcSEcCtD
Cefixime—Dyspepsia—Temozolomide—melanoma	0.000296	0.0045	CcSEcCtD
Cefixime—Body temperature increased—Dactinomycin—melanoma	0.000294	0.00447	CcSEcCtD
Cefixime—Abdominal pain—Dactinomycin—melanoma	0.000294	0.00447	CcSEcCtD
Cefixime—Hypersensitivity—Bleomycin—melanoma	0.000294	0.00446	CcSEcCtD
Cefixime—Gastrointestinal pain—Carmustine—melanoma	0.000285	0.00432	CcSEcCtD
Cefixime—Pruritus—Bleomycin—melanoma	0.000282	0.00429	CcSEcCtD
Cefixime—Abdominal pain—Carmustine—melanoma	0.000275	0.00418	CcSEcCtD
Cefixime—Body temperature increased—Carmustine—melanoma	0.000275	0.00418	CcSEcCtD
Cefixime—Gastrointestinal pain—Temozolomide—melanoma	0.000275	0.00418	CcSEcCtD
Cefixime—Hypersensitivity—Dactinomycin—melanoma	0.000274	0.00416	CcSEcCtD
Cefixime—Urticaria—Temozolomide—melanoma	0.000268	0.00406	CcSEcCtD
Cefixime—Body temperature increased—Temozolomide—melanoma	0.000266	0.00404	CcSEcCtD
Cefixime—Abdominal pain—Temozolomide—melanoma	0.000266	0.00404	CcSEcCtD
Cefixime—Hypersensitivity—Carmustine—melanoma	0.000257	0.0039	CcSEcCtD
Cefixime—Diarrhoea—Dactinomycin—melanoma	0.000255	0.00387	CcSEcCtD
Cefixime—Vomiting—Bleomycin—melanoma	0.000254	0.00385	CcSEcCtD
Cefixime—Rash—Bleomycin—melanoma	0.000252	0.00382	CcSEcCtD
Cefixime—Dermatitis—Bleomycin—melanoma	0.000251	0.00382	CcSEcCtD
Cefixime—Hypersensitivity—Temozolomide—melanoma	0.000248	0.00376	CcSEcCtD
Cefixime—Leukopenia—Docetaxel—melanoma	0.000246	0.00373	CcSEcCtD
Cefixime—Diarrhoea—Carmustine—melanoma	0.000238	0.00362	CcSEcCtD
Cefixime—Pruritus—Temozolomide—melanoma	0.000238	0.00361	CcSEcCtD
Cefixime—Convulsion—Docetaxel—melanoma	0.000238	0.00361	CcSEcCtD
Cefixime—Nausea—Bleomycin—melanoma	0.000237	0.0036	CcSEcCtD
Cefixime—Vomiting—Dactinomycin—melanoma	0.000237	0.00359	CcSEcCtD
Cefixime—Rash—Dactinomycin—melanoma	0.000235	0.00356	CcSEcCtD
Cefixime—Dizziness—Carmustine—melanoma	0.00023	0.0035	CcSEcCtD
Cefixime—Diarrhoea—Temozolomide—melanoma	0.00023	0.0035	CcSEcCtD
Cefixime—Anaphylactic shock—Docetaxel—melanoma	0.000224	0.0034	CcSEcCtD
Cefixime—Dizziness—Temozolomide—melanoma	0.000223	0.00338	CcSEcCtD
Cefixime—Vomiting—Carmustine—melanoma	0.000222	0.00336	CcSEcCtD
Cefixime—Nausea—Dactinomycin—melanoma	0.000221	0.00336	CcSEcCtD
Cefixime—Shock—Docetaxel—melanoma	0.00022	0.00334	CcSEcCtD
Cefixime—Rash—Carmustine—melanoma	0.00022	0.00333	CcSEcCtD
Cefixime—Dermatitis—Carmustine—melanoma	0.00022	0.00333	CcSEcCtD
Cefixime—Thrombocytopenia—Docetaxel—melanoma	0.000219	0.00333	CcSEcCtD
Cefixime—Headache—Carmustine—melanoma	0.000218	0.00331	CcSEcCtD
Cefixime—Vomiting—Temozolomide—melanoma	0.000214	0.00325	CcSEcCtD
Cefixime—Rash—Temozolomide—melanoma	0.000212	0.00322	CcSEcCtD
Cefixime—Dermatitis—Temozolomide—melanoma	0.000212	0.00322	CcSEcCtD
Cefixime—Headache—Temozolomide—melanoma	0.000211	0.0032	CcSEcCtD
Cefixime—Nausea—Carmustine—melanoma	0.000207	0.00314	CcSEcCtD
Cefixime—Nausea—Temozolomide—melanoma	0.0002	0.00303	CcSEcCtD
Cefixime—Dyspepsia—Docetaxel—melanoma	0.000197	0.00299	CcSEcCtD
Cefixime—Gastrointestinal pain—Docetaxel—melanoma	0.000183	0.00278	CcSEcCtD
Cefixime—Abdominal pain—Docetaxel—melanoma	0.000177	0.00269	CcSEcCtD
Cefixime—Body temperature increased—Docetaxel—melanoma	0.000177	0.00269	CcSEcCtD
Cefixime—Hypersensitivity—Docetaxel—melanoma	0.000165	0.0025	CcSEcCtD
Cefixime—Pruritus—Docetaxel—melanoma	0.000158	0.0024	CcSEcCtD
Cefixime—Diarrhoea—Docetaxel—melanoma	0.000153	0.00232	CcSEcCtD
Cefixime—Dizziness—Docetaxel—melanoma	0.000148	0.00225	CcSEcCtD
Cefixime—Vomiting—Docetaxel—melanoma	0.000142	0.00216	CcSEcCtD
Cefixime—Rash—Docetaxel—melanoma	0.000141	0.00214	CcSEcCtD
Cefixime—Dermatitis—Docetaxel—melanoma	0.000141	0.00214	CcSEcCtD
Cefixime—Headache—Docetaxel—melanoma	0.00014	0.00213	CcSEcCtD
Cefixime—Nausea—Docetaxel—melanoma	0.000133	0.00202	CcSEcCtD
Cefixime—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	0.000118	0.0541	CbGpPWpGaD
Cefixime—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A2—melanoma	0.000114	0.0521	CbGpPWpGaD
Cefixime—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	0.00011	0.0502	CbGpPWpGaD
Cefixime—Ceftriaxone—ALB—melanoma	8.54e-05	0.0133	CrCbGaD
Cefixime—Cefalotin—ALB—melanoma	7.48e-05	0.0117	CrCbGaD
Cefixime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	6.97e-05	0.0318	CbGpPWpGaD
Cefixime—Cephalexin—ALB—melanoma	6.8e-05	0.0106	CrCbGaD
Cefixime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—melanoma	6.72e-05	0.0307	CbGpPWpGaD
Cefixime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	6.46e-05	0.0295	CbGpPWpGaD
Cefixime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A11—melanoma	5.68e-05	0.026	CbGpPWpGaD
Cefixime—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	4.91e-05	0.0225	CbGpPWpGaD
Cefixime—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	4.56e-05	0.0208	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—ABCB5—melanoma	3.13e-05	0.0143	CbGpPWpGaD
Cefixime—SLC15A2—SLC-mediated transmembrane transport—SLC17A5—melanoma	3.11e-05	0.0142	CbGpPWpGaD
Cefixime—SLC15A1—SLC-mediated transmembrane transport—SLC15A2—melanoma	3e-05	0.0137	CbGpPWpGaD
Cefixime—SLC22A5—SLC-mediated transmembrane transport—SLC15A2—melanoma	2.95e-05	0.0135	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—ABCB5—melanoma	2.9e-05	0.0133	CbGpPWpGaD
Cefixime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	2.89e-05	0.0132	CbGpPWpGaD
Cefixime—SLC15A1—SLC-mediated transmembrane transport—SLC17A5—melanoma	2.89e-05	0.0132	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—ABCB5—melanoma	2.86e-05	0.0131	CbGpPWpGaD
Cefixime—SLC22A5—SLC-mediated transmembrane transport—SLC17A5—melanoma	2.84e-05	0.013	CbGpPWpGaD
Cefixime—SLC15A2—SLC-mediated transmembrane transport—SLC6A11—melanoma	2.83e-05	0.0129	CbGpPWpGaD
Cefixime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	2.68e-05	0.0123	CbGpPWpGaD
Cefixime—SLC15A1—SLC-mediated transmembrane transport—SLC6A11—melanoma	2.62e-05	0.012	CbGpPWpGaD
Cefixime—SLC22A5—SLC-mediated transmembrane transport—SLC6A11—melanoma	2.58e-05	0.0118	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—ARL2—melanoma	2.17e-05	0.00991	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—ARL2—melanoma	2.01e-05	0.0092	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—ARL2—melanoma	1.98e-05	0.00905	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—SLC17A5—melanoma	1.58e-05	0.00723	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—SLC15A2—melanoma	1.53e-05	0.00697	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—SLC15A2—melanoma	1.5e-05	0.00686	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—SLC17A5—melanoma	1.47e-05	0.00671	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—SLC17A5—melanoma	1.44e-05	0.0066	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—SLC6A11—melanoma	1.44e-05	0.00657	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—SLC6A11—melanoma	1.33e-05	0.00609	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—SLC6A11—melanoma	1.31e-05	0.00599	CbGpPWpGaD
Cefixime—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—melanoma	1.29e-05	0.00591	CbGpPWpGaD
Cefixime—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—melanoma	1.2e-05	0.00548	CbGpPWpGaD
Cefixime—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—melanoma	1.18e-05	0.00539	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—SLC5A5—melanoma	6.57e-06	0.003	CbGpPWpGaD
Cefixime—SLC15A2—SLC-mediated transmembrane transport—ALB—melanoma	6.17e-06	0.00282	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—SLC5A5—melanoma	6.1e-06	0.00279	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—SLC5A5—melanoma	5.99e-06	0.00274	CbGpPWpGaD
Cefixime—SLC15A1—SLC-mediated transmembrane transport—ALB—melanoma	5.72e-06	0.00262	CbGpPWpGaD
Cefixime—SLC22A5—SLC-mediated transmembrane transport—ALB—melanoma	5.63e-06	0.00257	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—ABCB1—melanoma	5.01e-06	0.00229	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—ABCB1—melanoma	4.65e-06	0.00212	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—ABCB1—melanoma	4.57e-06	0.00209	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—ALB—melanoma	3.13e-06	0.00143	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—ALB—melanoma	2.91e-06	0.00133	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—ALB—melanoma	2.86e-06	0.00131	CbGpPWpGaD
